KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Evolent Health (EVH) Preferred Shares Issued (2023)

Evolent Health has reported Preferred Shares Issued over the past 1 years, most recently at $168.0 million for Q1 2023.

For Q1 2023, Preferred Shares Issued changed N/A year-over-year to $168.0 million; the TTM value through Dec 2023 reached $168.0 million, changed N/A, while the annual FY2023 figure was $168.0 million, N/A changed from the prior year.
Preferred Shares Issued for Q1 2023 was $168.0 million at Evolent Health.
Over five years, Preferred Shares Issued peaked at $168.0 million in Q1 2023 and troughed at $168.0 million in Q1 2023.